| This week's sponsor is Premier Research. | | | A $20B Opportunity: The Future of Cannabis-Based Therapies
The market for cannabis-based therapies is expected to top $20 billion in three years. How can you make the most of this opportunity? Attend our May 9 webinar, for starters. Register today. Premier Research. It's what we do. Best. |
Featured Story Friday, April 7, 2017 Johnson & Johnson has become the latest Big Pharma to turn to PeptiDream for help discovering and optimizing peptide therapeutics. J&J is paying up to $1.15 billion to enlist PeptiDream to aim its peptide discovery platform at multiple cardiovascular and metabolic targets. | This week's sponsor is Sensors Expo & Conference 2017. | | | |
Top Stories Friday, April 7, 2017 Vifor Pharma has become an independent company following the IPO of its sister unit, Galenica Santé. The split and stock listing gives Vifor money to pay off debt it accrued in its $1.5 billion (€1.4 billion) takeover of Relypsa and continue the accelerated period of investment it initiated to prepare for life on its own. Friday, April 7, 2017 Israel's Bioblast Pharma has abandoned plans for a securities offering, blaming what it called "adverse market conditions" for the decision. Friday, April 7, 2017 Medivir has posted data from a phase 2 trial of its histone deacetylase inhibitor in patients with cutaneous T-cell lymphoma. One regimen of the treatment triggered responses in 40% of subjects, a finding that has encouraged Medivir to push ahead with plans to start a phase 3 trial later this year. Friday, April 7, 2017 University of Pennsylvania scientists have devised a new imaging test to measure the amount of PARP-1 enzyme in ovarian cancer patients, which could help identify which patients would benefit most from treatment that targets PARP-1. Friday, April 7, 2017 One of the primary goals of regenerative medicine is to find new ways of fighting heart disease. Coaxing stem cells to become heart cells is one popular technique, but scientists at the University of Illinois at Chicago believe they might have found an even better way to repair damaged hearts—by transforming skin cells into blood vessels. Thursday, April 6, 2017 In this week's EuroBiotech Report, Astellas moves to buy Ogeda, Verona files for IPO, Merck KGaA spinoff pens IBD pact and more. Friday, April 7, 2017 Gilead is planning its first manufacturing facility outside of the U.S. in China, Takeda inked a deal to develop an IBD drug from Finch Therapeutics, and the Japanese pharma cuts 180 workers at Ariad after the $5.2 billion buyout. Thursday, April 6, 2017 Sanofi Genzyme's CEO Meeker will step down amid key rollouts, Allergan's chief strategy officer Patel became CEO at startup Relay, Sarepta tapped Amgen and Regeneron alum Stehman-Breen as CMO. | This week's sponsor is J.P.Morgan. | | | How Pre-Transaction Planning Can Maximize Your Wealth
If you are a founder or executive of a healthcare business and are anticipating its sale or initial public offering, J.P. Morgan Private Bank can help maximize the value of your equity interests. Download this article on pre-transaction planning now. |
| | | Novartis in-licensed a midphase ophthalmic asset from Lubris. Release Nanobiotix raised $27 million to fund head and neck cancer clinical trials. Statement AbbVie posted a more detailed look at phase 2b data on its uterine fibroid candidate elagolix. Release | |
|
Resources Sponsored By: LMK Clinical Research Consulting Training is a vital component of workplace efficiency especially when it comes to one of the most important deliverables of a clinical trial – the Trial Master File (TMF). Sponsored By: DocuSign DocuSign’s eSignature solutions modernize healthcare and life science organizations by eliminating paper and antiquated signature processes while meeting compliance requirements and reducing costs and errors. Sponsored By: DocuSign The patients who rely on your scientific leadership are expecting more. Sponsored By: DocuSign The U.S. Department of Justice has collected upwards of $17 billion in settlements from the healthcare industry since 2009, including more than $2 billion from a single life sciences company. Sponsored By: Veeva This white paper focuses on engaging healthcare stakeholders effectively while integrating your medical and commercial teams. Presented By: Veeva Share your thoughts on the life sciences industry’s progress in reducing system and process complexity to improve study execution. The first 50 qualified respondents will receive a $10 Amazon gift card, as well as a $10 donation made to Doctors Without Borders in their name. Finish the survey today! Presented By: Enterprise Florida As life sciences companies decide to implement shared services, a major concern is real estate costs for a facility. Download this Whitepaper to learn why Florida is gaining traction as a prime location for shared services. MIXiii-BIOMED 2017 May 23-25, 2017 | Tel Aviv, Israel 2017 BIO International Convention: The Largest Global Biotech Partnering Event of the Year June 19-22 | San Diego, CA Drug Development Boot Camp® 2017 November 15-16, 2017 | Boston, MA Medical Sensors Design Conference May 8-9, 2017 │ Boston Marriott Newton │ Newton, MA |
